surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 A Study of Tirzepatide (LY3298176)
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 A Study of Tirzepatide (LY3298176)](https://images.ctfassets.net/tkom1vk0n4w2/5gVgupxqOguWuxD431W7Sq/f8d330a42d35fe73ad90a905d9daa81e/LLYPBRDK0026_CA_Eli_Lilly_Richard_Stanley_0299_V2_sRGB.webp)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 A Study of Tirzepatide (LY3298176)](https://www.researchgate.net/publication/362493849/figure/fig4/AS:11431281461588462@1748178345744/Body-weight-loss-with-tirzepatide-in-SURPASS-1-556-73-76-87-Data-are-estimated-mean-SE.png)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 A Study of Tirzepatide (LY3298176)](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40265-022-01746-8/MediaObjects/40265_2022_1746_Figa_HTML.png)

























